Evidence map›Paper›PMID 41907386›Full record

ArticleJournal of materials chemistry. C2026

Through-bond

Amira A C Hartmann, Vincenzo Brancaccio, Krzysztof Radacki, Holger Braunschweig, Prince Ravat

Abstract read
In one paragraph

Article in Journal of materials chemistry. C, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amira A C HartmannDepartment of Chemistry and Biochemistry, Institute of Organic Chemistry, University of Cologne 50939 Cologne Germany pravat@uni-koeln.de.ORCID https://orcid.org/0009-0009-5788-3880
Vincenzo BrancaccioInstitut für Organische Chemie, Julius-Maximilians-Universität Würzburg Am Hubland D-97074 Würzburg Germany.
Krzysztof RadackiInstitut für Anorganische Chemie and Institute for Sustainable Chemistry & Catalysis with Boron, Julius-Maximilians-Universität Würzburg Am Hubland D-97074 Würzburg Germany.ORCID https://orcid.org/0000-0003-3088-6327
Holger BraunschweigInstitut für Anorganische Chemie and Institute for Sustainable Chemistry & Catalysis with Boron, Julius-Maximilians-Universität Würzburg Am Hubland D-97074 Würzburg Germany.ORCID https://orcid.org/0000-0001-9264-1726
Prince RavatDepartment of Chemistry and Biochemistry, Institute of Organic Chemistry, University of Cologne 50939 Cologne Germany pravat@uni-koeln.de.ORCID https://orcid.org/0000-0002-7553-9188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a novel class of bisbenzimidazole-fused [8]helicenes ([8]HBIs) that integrates a configurationally stable helical scaffold with two proton-responsive benzimidazole units. Three distinct regioisomers, generated through twofold imidization of [8]helicene dianhydride, provide a modular platform for systematically tuning through-bond and through-space π-conjugation. Relative to the diimide analogue [8]helicene diimide, the [8]HBIs exhibit significantly enhanced π-delocalization, as reflected in red-shifted absorption and emission, reduced optical and electrochemical gaps, and improved photophysical performance. Crucially, reversible protonation induces helical compression and reorganization of electronic structure, resulting in pronounced bathochromic shifts in circular dichroism (CD) and circularly polarized luminescence (CPL), while preserving large dissymmetry factors (|

Identifiers

PMID41907386
PMCPMC13022832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.